WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

Alterations in ATCvet codes

 Alterations included in the ATCvet Index valid from 2017

Previous ATCvet codeATCvet level name New ATCvet code
QA01AD02 1)benzydamine QR02AX03
QJ05AX69sofosbuvir and velpatasvirQJ05AP55
QJ05AX68elbasvir and grazoprevir QJ05AP54
QJ05AX67ombitasvir, paritaprevir and ritonavir QJ05AP53
QJ05AX66dasabuvir, ombitasvir, paritaprevir and ritonavir QJ05AP52
QJ05AX65sofosbuvir and ledipasvirQJ05AP51
QJ05AX16dasabuvirQJ05AP09
QJ05AX15sofosbuvirQJ05AP08
QJ05AX14daclatasvirQJ05AP07
QJ05AE15asunaprevirQJ05AP06
QJ05AE14simeprevir QJ05AP05
QJ05AE13faldaprevirQJ05AP04
QJ05AE12boceprevirQJ05AP03
QJ05AE11telaprevirQJ05AP02
QJ05AB04ribavirinQJ05AP01
QJ01DD54 3)ceftriaxone, combinationsQJ01DD63
QH01BA06argipressinQH01BA01 2)
1) Split of code. Alteration of ATCvet code applies only for benzydamine lozenges
2) New ATCvet level name vasopressin (argipressin)
3) Split of code. Combinations of ceftriaxone and other substances remain in QJ01DD54 while combinations of ceftriaxone and beta-lactamase inhibitors are moved to QJ01DD63 ceftriaxone and beta-lactamase inhibitor

Other alterations in ATCvet 2018

Alterations included in the ATCvet Index valid from 2018

ATCvet codePrevious ATCvet level name New ATCvet level name or new ATCvet level
QA05AABile acid preparationsBile acids and derivatives
QB02BD08eptacog alfacoagulation factor VIIa
QJ01CR01ampicillin and enzyme inhibitorampicillin and beta-lactamase inhibitor
QJ01CR02amoxicillin and enzyme inhibitoramoxicillin and beta-lactamase inhibitor
QJ01CR03ticarcillin and enzyme inhibitorticarcillin and beta-lactamase inhibitor
QJ01CR05piperacillin and enzyme inhibitorpiperacillin and beta-lactamase inhibitor
QJ01DD51cefotaxime, combinationscefotaxime and beta-lactamase inhibitor
QJ01DD52ceftazidime, combinationsceftazidime and beta-lactamase inhibitor
QJ01DD62cefoperazone, combinationscefoperazone and beta-lactamase inhibitor
QJ01DH51imipenem and enzyme inhibitorimipenem and cilastatin
QJ01DI54ceftolozane and enzyme inhibitorceftolozane and beta-lactamase inhibitor
QJ05APAntivirals for treatment of HCV infections
QL01XC05gemtuzumabgemtuzumab ozogamicin
QR03ALAdrenergics in combinations with anticholinergicsAdrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids

Last updated: 2017-12-12